Chronix Biomedical Stock

At Manningham Medical Centre, you can find all the data about Chronix Biomedical Stock. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

Chronix Biomedical Inc - Company Profile and News

https://www.bloomberg.com/profile/company/8169848Z:US

Chronix Biomedical, Inc. operates as a molecular diagnostic company. The Company develops technology for monitoring and management of cancers and neurologic diseases, as well as blood tests.

Oncocyte Announces Definitive Agreement to Acquire …

https://www.nasdaq.com/press-release/oncocyte-announces-definitive-agreement-to-acquire-chronix-biomedical-inc.-2021-02-02

Upon closing, Oncocyte will deliver closing consideration of $2.675 million in cash and $1.5 million of Oncocyte common stock (or approximately 295,000 shares) and …

Oncocyte Announces Definitive Agreement to Acquire Chronix …

https://finance.yahoo.com/news/oncocyte-announces-definitive-agreement-acquire-130000065.html

Upon closing, Oncocyte will deliver closing consideration of $2.675 million in cash and $1.5 million of Oncocyte common stock (or approximately 295,000 shares) and …

Oncocyte to acquire Chronix Biomedical - SeekingAlpha

https://seekingalpha.com/news/3657158-oncocyte-to-acquire-chronix-biomedical

Feb. 02, 2021 8:10 AM ET OncoCyte Corporation (OCX) OCX By: Gaurav Batavia, SA News Editor Oncocyte Corporation (NYSEMKT: OCX) to acquire through its …

Oncocyte Announces Definitive Agreement to Acquire …

https://www.globenewswire.com/news-release/2021/02/02/2168130/0/en/Oncocyte-Announces-Definitive-Agreement-to-Acquire-Chronix-Biomedical-Inc.html

Upon closing, Oncocyte will deliver closing consideration of $2.675 million in cash and $1.5 million of Oncocyte common stock (or approximately 295,000 shares) and …

Chronix Biomedical - Crunchbase Company …

https://www.crunchbase.com/organization/chronix-biomedical

Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary …

Oncocyte Acquires Blood-Based Molecular Diagnostics …

https://markets.businessinsider.com/news/stocks/oncocyte-acquires-blood-based-molecular-diagnostics-provider-chronix-biomedical-for-roughly-10-million-1030033683

Oncocyte Acquires Blood-Based Molecular Diagnostics Provider, Chronix Biomedical For Roughly $10 Million Vandana Singh, Benzinga Feb. 2, 2021, 09:35 AM …

Oncocyte acquires Chronix Biomedical

https://www.massdevice.com/oncocyte-acquires-chronix-biomedical/

Under an amended merger agreement, Oncocyte delivered closing consideration and paid off assumed liabilities reaching approximately $4.25 million in …

Chronix Biomedical Company Profile: Acquisition

https://pitchbook.com/profiles/company/51006-52

The company's blood test comprises diagnostics test kits that are used for the detection and monitoring of various stages of chronic diseases in human beings and animals, enabling …